Related Experiment Video
Updated: Feb 27, 2026
10:44
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
2.0K
Transcription factor decoy technology: A therapeutic update.
Markus Hecker1, Andreas H Wagner1
1Department of Cardiovascular Physiology, Heidelberg University, D-69120 Heidelberg, Germany.
Biochemical Pharmacology
|June 24, 2017
Summary
Transcription factor decoy (TFD) oligodeoxynucleotides (ODN) offer a novel therapeutic approach by neutralizing disease-promoting transcription factors. Research explores TFD modifications and delivery methods to enhance stability and efficacy for treating various diseases.
Area of Science:
- Molecular Biology
- Pharmacology
- Gene Therapy
Background:
- Aberrantly activated transcription factors drive disease pathogenesis.
- Transcription factor decoy (TFD) oligodeoxynucleotides (ODN) are designed to specifically target and neutralize these factors.
- TFDs function by mimicking DNA binding sites in gene promoters.
Purpose of the Study:
- To elucidate the mechanism of action for TFD molecules.
- To review structural modifications enhancing TFD stability and efficacy.
- To discuss advanced drug delivery systems for TFDs.
Main Methods:
- Investigating TFD mechanism of action.
- Analyzing structural modifications (e.g., hairpin, circular ODNs) for improved stability.
- Evaluating drug delivery strategies (e.g., ultrasound-targeted microbubbles, AAV vectors).
Main Results:
- TFDs can specifically target and neutralize disease-associated transcription factors.
- Structural modifications and advanced delivery systems show potential for enhanced therapeutic outcomes.
- Current therapeutic applications of TFD ODNs are being summarized.
Conclusions:
- TFDs represent a promising nucleic acid-based therapeutic class.
- Optimizing TFD stability and delivery is crucial for clinical success.
- Further research into TFD applications could lead to new disease treatments.
More Related Videos
10:28Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
7.0K
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
6.0K
Related Concept Videos
02:16Transcription Factors
83.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
83.2K
01:52Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
02:04Co-activators and Co-repressors
8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
02:33Combinatorial Gene Control
9.8K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.8K
01:30General Transcription Factors
7.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.3K
02:15Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K